Rockefeller Capital Management’s Annovis Bio ANVS Stock Holding History

Rockefeller Capital Management’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.23K	Hold	1,000	–	–	﹤0.01%	4398
2025 Q4	$3.46K	Hold	1,000	–	–	﹤0.01%	4177
2025 Q3	$2.07K	Buy	+1,000	New	+$2.5K	﹤0.01%	4085
2023 Q1	–	Sell	-1,000	Closed	-$13K	–	2064
2022 Q4	$13K	Hold	1,000	–	–	﹤0.01%	2951
2022 Q3	$13K	Hold	1,000	–	–	﹤0.01%	2955
2022 Q2	$11K	Hold	1,000	–	–	﹤0.01%	3050
2022 Q1	$13K	Hold	1,000	–	–	﹤0.01%	2903
2021 Q4	$17K	Hold	1,000	–	–	﹤0.01%	2703
2021 Q3	$31K	Hold	1,000	–	–	﹤0.01%	2377
2021 Q2	$85K	Hold	1,000	–	–	﹤0.01%	1860
2021 Q1	$27K	Hold	1,000	–	–	﹤0.01%	2143
2020 Q4	$7K	Buy	+1,000	New	+$5.41K	﹤0.01%	2323

Other funds holding ANVS

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Rockefeller Capital Management's ANVS Position: Q1 2026 in Review

Rockefeller Capital Management held its Annovis Bio (ANVS) position steady in Q1 2026 at 1,000 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #4398.

Rockefeller Capital Management first reported a position in ANVS in Q4 2020 and has held it in 12 quarters since. The position peaked at $85K in Q2 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

Rockefeller Capital Management held 1,000 shares of Annovis Bio worth $2.23K as of Q1 2026.
Rockefeller Capital Management left its Annovis Bio share count unchanged in Q1 2026.
Annovis Bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4398 holding.
Rockefeller Capital Management first reported a position in Annovis Bio in Q4 2020 and has held it in 12 quarters since.
Rockefeller Capital Management's Annovis Bio position peaked at $85K in Q2 2021.
56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.